Agilent Technologies Inc (0HAV.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-07-31 2025-06-30 2025-04-30 2025-03-31
Revenue 1,738,000,000 3,681,000,000 1,668,000,000 3,130,000,000
Cost of Revenue 824,000,000 1,878,000,000 802,000,000 1,785,000,000
Gross Profit 914,000,000 1,803,000,000 866,000,000 1,345,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 417,000,000 39,000,000 454,000,000 42,000,000
Operating Expenses 554,000,000 113,000,000 566,000,000 115,000,000
Operating Income 360,000,000 1,690,000,000 300,000,000 1,230,000,000
Interest Expense 28,000,000 86,400,580 29,000,000 95,709,935
Income Before Tax 366,000,000 1,358,000,000 260,000,000 1,059,000,000
Income Tax Expense 30,000,000 102,000,000 45,000,000 278,000,000
Net Income 336,000,000 811,000,000 215,000,000 474,000,000
Per Share
EPS 1.18 0.47 0.75 0.27
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2024-10-31 2023-10-31 2022-10-31
Revenue 12,922,000,000 6,510,000,000 6,833,000,000 6,848,000,000
Cost of Revenue 7,961,000,000 2,975,000,000 3,368,000,000 3,162,000,000
Gross Profit 4,961,000,000 3,535,000,000 3,465,000,000 3,686,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 115,000,000 1,518,000,000 1,634,000,000 1,637,000,000
Operating Expenses 777,000,000 2,047,000,000 2,115,000,000 2,104,000,000
Operating Income 4,184,000,000 1,488,000,000 1,350,000,000 1,582,000,000
Interest Expense 407,450,138 96,000,000 95,000,000 82,000,000
Income Before Tax 4,608,000,000 1,521,000,000 1,339,000,000 1,504,000,000
Income Tax Expense 1,520,000,000 232,000,000 99,000,000 250,000,000
Net Income 2,144,000,000 1,289,000,000 1,240,000,000 1,254,000,000
Per Share
EPS 1.22 4.44 4.22 4.19
EPS Diluted 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-04-30 2024-12-31 2024-10-31 2023-10-31
Assets
Cash and Cash Equivalents 1,329,000,000 4,074,000,000 1,329,000,000 1,590,000,000
Short Term Investments 0 0 0 0
Net Receivables 1,324,000,000 1,363,000,000 1,324,000,000 1,291,000,000
Inventory 991,000,000 1,942,000,000 991,000,000 1,031,000,000
Total Current Assets 3,959,000,000 7,632,000,000 3,959,000,000 4,186,000,000
Property Plant Equipment 1,955,000,000 28,641,000,000 1,955,000,000 1,424,000,000
Goodwill and Intangibles 5,021,000,000 3,163,000,000 5,021,000,000 4,435,000,000
Total Assets 11,846,000,000 47,626,000,000 11,846,000,000 10,763,000,000
Liabilities
Account Payables 540,000,000 655,000,000 540,000,000 418,000,000
Short Term Debt 87,000,000 84,000,000 87,000,000 0
Total Current Liabilities 1,895,000,000 2,642,000,000 1,895,000,000 1,603,000,000
Long Term Debt 3,487,000,000 5,172,000,000 3,487,000,000 2,853,000,000
Total Liabilities 5,948,000,000 14,370,000,000 5,948,000,000 4,918,000,000
Shareholders Equity
Retained Earnings 750,000,000 -5,269,000,000 750,000,000 782,000,000
Total Shareholders Equity 5,898,000,000 24,290,000,000 5,898,000,000 5,845,000,000
Balance Sheet (Annual) 2025-04-30 2024-12-31 2024-10-31 2023-10-31 2022-10-31
Assets
Cash and Cash Equivalents 1,329,000,000 4,074,000,000 1,329,000,000 1,590,000,000 1,053,000,000
Short Term Investments 0 0 0 0 0
Net Receivables 1,324,000,000 1,363,000,000 1,324,000,000 1,291,000,000 1,492,000,000
Inventory 991,000,000 1,942,000,000 991,000,000 1,031,000,000 1,038,000,000
Total Current Assets 3,959,000,000 7,632,000,000 3,959,000,000 4,186,000,000 3,778,000,000
Property Plant Equipment 1,955,000,000 28,641,000,000 1,955,000,000 1,424,000,000 1,250,000,000
Goodwill and Intangibles 5,021,000,000 3,163,000,000 5,021,000,000 4,435,000,000 4,773,000,000
Total Assets 11,846,000,000 47,626,000,000 11,846,000,000 10,763,000,000 10,532,000,000
Liabilities
Account Payables 540,000,000 655,000,000 540,000,000 418,000,000 580,000,000
Short Term Debt 87,000,000 84,000,000 87,000,000 0 87,000,000
Total Current Liabilities 1,895,000,000 2,642,000,000 1,895,000,000 1,603,000,000 1,861,000,000
Long Term Debt 3,487,000,000 5,172,000,000 3,487,000,000 2,853,000,000 2,733,000,000
Total Liabilities 5,948,000,000 14,370,000,000 5,948,000,000 4,918,000,000 5,227,000,000
Shareholders Equity
Retained Earnings 750,000,000 -5,269,000,000 750,000,000 782,000,000 324,000,000
Total Shareholders Equity 5,898,000,000 24,290,000,000 5,898,000,000 5,845,000,000 5,305,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2024-10-31 2023-10-31 2022-10-31
Operating Activities
Net Income 2,144,000,000 1,289,000,000 1,240,000,000 1,254,000,000
Depreciation & Amortization 1,411,000,000 257,000,000 271,000,000 317,000,000
Stock Based Compensation 65,000,000 129,000,000 111,000,000 126,000,000
Change in Working Capital -430,000,000 83,000,000 -116,000,000 -478,000,000
Operating Cash Flow 4,491,000,000 1,751,000,000 1,772,000,000 1,312,000,000
Investing Activities
Capital Expenditure -3,174,000,000 -378,000,000 -298,000,000 -291,000,000
Investments -3,174,000,000 -378,000,000 -298,000,000 -291,000,000
Investing Cash Flow -2,764,000,000 -1,258,000,000 -310,000,000 -338,000,000
Financing Activities
Debt Repayment -14,000,000 637,000,000 -35,000,000 -26,000,000
Common Stock Issued/Repurchased -498,000,000 -1,150,000,000 -575,000,000 -1,081,000,000
Dividends Paid -696,000,000 -274,000,000 -265,000,000 -250,000,000
Financing Cash Flow -1,795,000,000 -752,000,000 -930,000,000 -1,372,000,000
Summary
Free Cash Flow 1,317,000,000 1,373,000,000 1,474,000,000 1,021,000,000
Net Change in Cash -74,000,000 -261,000,000 537,000,000 -431,000,000
Cash Flow Statement (Annual) 2024-12-31 2024-10-31 2023-10-31 2022-10-31
Operating Activities
Net Income 2,144,000,000 1,289,000,000 1,240,000,000 1,254,000,000
Depreciation & Amortization 1,411,000,000 257,000,000 271,000,000 317,000,000
Stock Based Compensation 65,000,000 129,000,000 111,000,000 126,000,000
Change in Working Capital -430,000,000 83,000,000 -116,000,000 -478,000,000
Operating Cash Flow 4,491,000,000 1,751,000,000 1,772,000,000 1,312,000,000
Investing Activities
Capital Expenditure -3,174,000,000 -378,000,000 -298,000,000 -291,000,000
Investments -3,174,000,000 -378,000,000 -298,000,000 -291,000,000
Investing Cash Flow -2,764,000,000 -1,258,000,000 -310,000,000 -338,000,000
Financing Activities
Debt Repayment -14,000,000 637,000,000 -35,000,000 -26,000,000
Common Stock Issued/Repurchased -498,000,000 -1,150,000,000 -575,000,000 -1,081,000,000
Dividends Paid -696,000,000 -274,000,000 -265,000,000 -250,000,000
Financing Cash Flow -1,795,000,000 -752,000,000 -930,000,000 -1,372,000,000
Summary
Free Cash Flow 1,317,000,000 1,373,000,000 1,474,000,000 1,021,000,000
Net Change in Cash -74,000,000 -261,000,000 537,000,000 -431,000,000